Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Bosch

Showing results (381-390 of 681) with videos related to

Pageof 69
Sort By:
European Journal of Obstetrics, Gynecology, and Reproductive Biology|May 24, 2008
Age at sexual initiation and number of sexual partners in the female Spanish population Results from the AFRODITA surveySilvia de Sanjose, Xavier Cortés, Cristina Méndez, et al.
Vaccine|November 26, 2008
Recommendations for cervical cancer prevention in Latin America and the CaribbeanNubia Muñoz, Eduardo L Franco, Rolando Herrero, et al.
Medicine|June 1, 2017
Quick outpatient diagnosis in small district or general tertiary hospitals: A comparative observational studyElisabet Montori-Palacín, Sergio Prieto-González, Ignasi Carrasco-Miserachs, et al.
Plos One|September 16, 2021
Cost-effectiveness analysis of an intervention project engaging Traditional and Religious Leaders to improve uptake of childhood immunization in southern NigeriaAngela E Oyo-Ita, Patrick Hanlon, Ogonna Nwankwo, et al.
Revista Espanola De Cardiologia|April 24, 2004
[Differences in the management and prognosis of patients with non-ST segment elevation acute coronary syndrome according to the department of initial admission]Xavier Bosch, Fernando Verbal, Esteban López de Sá, et al.
International Journal of Cardiology|April 6, 2007
Causes of ineligibility in randomized controlled trials and long-term mortality in patients with non-ST-segment elevation acute coronary syndromesXavier Bosch, Victoria Delgado, Fernando Verbal, et al.
Infectious Agents and Cancer|January 1, 2013
Potential impact of a nine-valent vaccine in human papillomavirus related cervical diseaseBeatriz Serrano, Laia Alemany, Sara Tous, et al.
Vaccine|September 5, 2006
Chapter 29: Knowledge gaps and priorities for research on prevention of HPV infection and cervical cancerEduardo L Franco, F Xavier Bosch, Jack Cuzick, et al.
Vaccine|September 5, 2006
Chapter 30: HPV vaccines and screening in the prevention of cervical cancer; conclusions from a 2006 workshop of international expertsThomas C Wright, F Xavier Bosch, Eduardo L Franco, et al.
Vaccine|November 26, 2008
Cost-effectiveness of vaccination against cervical cancer: a multi-regional analysis assessing the impact of vaccine characteristics and alternative vaccination scenariosEugenio Suárez, Jennifer S Smith, F Xavier Bosch, et al.
Pageof 69

Showing results (381-390 of 681) with videos related to

Sort By:
Pageof 69
European Journal of Obstetrics, Gynecology, and Reproductive Biology|May 24, 2008
Age at sexual initiation and number of sexual partners in the female Spanish population Results from the AFRODITA surveySilvia de Sanjose, Xavier Cortés, Cristina Méndez, et al.
Vaccine|November 26, 2008
Recommendations for cervical cancer prevention in Latin America and the CaribbeanNubia Muñoz, Eduardo L Franco, Rolando Herrero, et al.
Medicine|June 1, 2017
Quick outpatient diagnosis in small district or general tertiary hospitals: A comparative observational studyElisabet Montori-Palacín, Sergio Prieto-González, Ignasi Carrasco-Miserachs, et al.
Plos One|September 16, 2021
Cost-effectiveness analysis of an intervention project engaging Traditional and Religious Leaders to improve uptake of childhood immunization in southern NigeriaAngela E Oyo-Ita, Patrick Hanlon, Ogonna Nwankwo, et al.
Revista Espanola De Cardiologia|April 24, 2004
[Differences in the management and prognosis of patients with non-ST segment elevation acute coronary syndrome according to the department of initial admission]Xavier Bosch, Fernando Verbal, Esteban López de Sá, et al.
International Journal of Cardiology|April 6, 2007
Causes of ineligibility in randomized controlled trials and long-term mortality in patients with non-ST-segment elevation acute coronary syndromesXavier Bosch, Victoria Delgado, Fernando Verbal, et al.
Infectious Agents and Cancer|January 1, 2013
Potential impact of a nine-valent vaccine in human papillomavirus related cervical diseaseBeatriz Serrano, Laia Alemany, Sara Tous, et al.
Vaccine|September 5, 2006
Chapter 29: Knowledge gaps and priorities for research on prevention of HPV infection and cervical cancerEduardo L Franco, F Xavier Bosch, Jack Cuzick, et al.
Vaccine|September 5, 2006
Chapter 30: HPV vaccines and screening in the prevention of cervical cancer; conclusions from a 2006 workshop of international expertsThomas C Wright, F Xavier Bosch, Eduardo L Franco, et al.
Vaccine|November 26, 2008
Cost-effectiveness of vaccination against cervical cancer: a multi-regional analysis assessing the impact of vaccine characteristics and alternative vaccination scenariosEugenio Suárez, Jennifer S Smith, F Xavier Bosch, et al.
Pageof 69